Key Takeaways
- ARR — Annual Recurring Revenue represents predictable revenue foundation for SaaS scalability.
- MEDDPICC — MEDDPICC sales methodology improves win rates in enterprise SaaS deal cycles.
- SaaS Unit Economics — Revenue per customer divided by acquisition cost defines sustainable SaaS unit economic models.
- GTM Architecture — Go-to-market strategy architecture aligns sales, marketing, and customer success functions.
Poor discovery is the most expensive problem in B2B SaaS sales, and it almost never shows up in the data as poor discovery. It shows up as late-stage deal loss, stalled proposals, and champions who go dark. The actual failure happened four weeks earlier in a discovery call where the AE got comfortable answers and moved on.
After reviewing hundreds of deal losses across PE-backed portfolio companies, the same seven questions appear consistently in the gaps. Reps who ask them regularly outsell those who don’t by measurable margins. Here is the audit.
Question 1: “What happens if you don’t solve this problem in the next 12 months?”
This is the cost-of-inaction question, and most reps skip it because they’re afraid the answer will be “not much.” That answer is exactly the intelligence you need. A buyer who can’t articulate real consequences for inaction hasn’t built the organizational urgency required to get a deal done. You can either help them build that urgency or deprioritize the deal. Both outcomes are better than carrying a dead deal to Q4.
When the answer is specific — “We’ll miss our compliance deadline and face fines” or “We’ll lose our two best analysts because they’re doing this manually” — you have the foundation of your value case.
Question 2: “Who else in the organization is affected by this problem?”
This question surfaces the stakeholder map and multi-threading opportunities simultaneously. The answer tells you whether this is a department-level pain point or an organizational one, which directly affects deal size potential and the level of Economic Buyer you should be engaging.
Question 3: “Have you tried to solve this before? What happened?”
Failed prior solutions reveal competitive history, organizational resistance to change, and implementation risk factors that will resurface in your deal. If they tried a competitor and it failed, you need to understand why — because procurement will ask about it, and your champion will be defending that question in committee.
Question 4: “What does success look like in 12 months, and how would you measure it?”
This is the Metrics question from MEDDPICC, and it belongs in discovery, not in the proposal stage. Reps who skip it end up writing ROI models that don’t match what the buyer actually measures. When your metrics don’t align with the CFO’s KPIs, your business case falls apart in the room where it matters most.
Question 5: “Who needs to be involved in the final decision, and what are each of their priorities?”
This question surfaces the committee structure and the competing agendas within it. A champion who says “just me” on a $200,000 deal is either mistaken about their authority or uncomfortable with multi-threading. Either way, this answer requires follow-up.
Question 6: “Is budget allocated for this, or does it need to be approved?”
There is a material difference between “we have budget for this” and “we think we can get budget for this.” Deals built on unconfirmed budget approvals have a fundamentally different risk profile than deals with committed funding. This distinction belongs in your CRM from the first discovery call.
Question 7: “What would cause you not to move forward with this project?”
This is the disqualification question, and most reps avoid it because they’re afraid of the answer. The answer is the most valuable thing you will learn in the entire discovery process. A buyer who says “we’d pause if our CFO prioritized cost reduction” has just told you that your deal is one board meeting away from being deprioritized. You now know to get the CFO engaged before that meeting rather than after.
Running this audit on your team’s discovery calls requires listening to recordings — not summaries, not CRM notes, actual calls. The seven questions above are almost never documented in CRM even when they’re asked, because the answers require interpretation, not just transcription.
Frequently Asked Questions
What are the most important questions to ask in a B2B discovery call?
The most critical discovery questions uncover pain severity (cost of inaction), stakeholder map, prior solution attempts, success metrics, decision process, budget status, and potential deal killers. Most reps focus on pain and solution fit while skipping budget reality and decision authority.
Why do AEs skip important discovery questions?
Reps skip hard questions because they fear disqualifying a deal or creating awkward moments. Ironically, these skipped questions are exactly what surfaces late-stage deal risk. Discomfort in discovery is vastly preferable to surprises at the committee stage.
How do you audit your team’s discovery calls?
Listen to actual call recordings — not CRM notes. Score calls against a standard question set. The seven questions above can serve as a discovery call scorecard. Review a sample of recent losses and compare discovery quality against recent wins.
